Featured Products

My Quote Request

No products added yet

6505-01-131-9687

20 Products

NDC00046-1048-82

FLUORESCEIN SODIUM OPHTHALMIC STRIPS,USP

NSN, MFG P/N

6505011319687

NSN

6505-01-131-9687

View More Info

NDC00046-1048-82

FLUORESCEIN SODIUM OPHTHALMIC STRIPS,USP

NSN, MFG P/N

6505011319687

NSN

6505-01-131-9687

MFG

WYETH

Description

IMMEDIATE CONTAINER QUANTITY: 100
IMMEDIATE CONTAINER TYPE: ENVELOPE
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 2 APPLICATOR STRIPS
SPECIAL FEATURES: 1.0 MG. FLUORESCEIN SODIUM PER STRIP
UNIT PACKAGE TYPE: BOX

MEDROL

METHYLPREDNISOLONE TABLETS,USP

NSN, MFG P/N

6505011315619

NSN

6505-01-131-5619

View More Info

MEDROL

METHYLPREDNISOLONE TABLETS,USP

NSN, MFG P/N

6505011315619

NSN

6505-01-131-5619

MFG

PHARMACIA & UPJOHN COMPANY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS METHYLPREDNISOLONE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE TABLETS USP 4MG I.S. 21S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 21 TABLETS PER PACKAGE; PACKAGE SHALL FACILITATE DIRECTION FOR A 6 DAY DRUG THERAPY REGIMEN OF 6 TABLETS ON DAY 1,5 ON DAY 2,4 ON DAY 3,ETC
THERAPEUTIC EQUIVALENT: MEDROL DOSEPAK BY UPJOHN

MEDROL DOSEPAK

METHYLPREDNISOLONE TABLETS,USP

NSN, MFG P/N

6505011315619

NSN

6505-01-131-5619

View More Info

MEDROL DOSEPAK

METHYLPREDNISOLONE TABLETS,USP

NSN, MFG P/N

6505011315619

NSN

6505-01-131-5619

MFG

PHARMACIA & UPJOHN COMPANY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS METHYLPREDNISOLONE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE TABLETS USP 4MG I.S. 21S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 21 TABLETS PER PACKAGE; PACKAGE SHALL FACILITATE DIRECTION FOR A 6 DAY DRUG THERAPY REGIMEN OF 6 TABLETS ON DAY 1,5 ON DAY 2,4 ON DAY 3,ETC
THERAPEUTIC EQUIVALENT: MEDROL DOSEPAK BY UPJOHN

MEDROL PAK COMP 21X4MG

METHYLPREDNISOLONE TABLETS,USP

NSN, MFG P/N

6505011315619

NSN

6505-01-131-5619

View More Info

MEDROL PAK COMP 21X4MG

METHYLPREDNISOLONE TABLETS,USP

NSN, MFG P/N

6505011315619

NSN

6505-01-131-5619

MFG

PFIZER SA

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS METHYLPREDNISOLONE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE TABLETS USP 4MG I.S. 21S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 21 TABLETS PER PACKAGE; PACKAGE SHALL FACILITATE DIRECTION FOR A 6 DAY DRUG THERAPY REGIMEN OF 6 TABLETS ON DAY 1,5 ON DAY 2,4 ON DAY 3,ETC
THERAPEUTIC EQUIVALENT: MEDROL DOSEPAK BY UPJOHN

MEDROL TABLETS

METHYLPREDNISOLONE TABLETS,USP

NSN, MFG P/N

6505011315619

NSN

6505-01-131-5619

View More Info

MEDROL TABLETS

METHYLPREDNISOLONE TABLETS,USP

NSN, MFG P/N

6505011315619

NSN

6505-01-131-5619

MFG

PHARMACIA & UPJOHN COMPANY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS METHYLPREDNISOLONE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE TABLETS USP 4MG I.S. 21S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 21 TABLETS PER PACKAGE; PACKAGE SHALL FACILITATE DIRECTION FOR A 6 DAY DRUG THERAPY REGIMEN OF 6 TABLETS ON DAY 1,5 ON DAY 2,4 ON DAY 3,ETC
THERAPEUTIC EQUIVALENT: MEDROL DOSEPAK BY UPJOHN

NDC00009-0056-04

METHYLPREDNISOLONE TABLETS,USP

NSN, MFG P/N

6505011315619

NSN

6505-01-131-5619

View More Info

NDC00009-0056-04

METHYLPREDNISOLONE TABLETS,USP

NSN, MFG P/N

6505011315619

NSN

6505-01-131-5619

MFG

PFIZER INC. DBA PFIZER

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS METHYLPREDNISOLONE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE TABLETS USP 4MG I.S. 21S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 21 TABLETS PER PACKAGE; PACKAGE SHALL FACILITATE DIRECTION FOR A 6 DAY DRUG THERAPY REGIMEN OF 6 TABLETS ON DAY 1,5 ON DAY 2,4 ON DAY 3,ETC
THERAPEUTIC EQUIVALENT: MEDROL DOSEPAK BY UPJOHN

NDC00364-0467-21

METHYLPREDNISOLONE TABLETS,USP

NSN, MFG P/N

6505011315619

NSN

6505-01-131-5619

View More Info

NDC00364-0467-21

METHYLPREDNISOLONE TABLETS,USP

NSN, MFG P/N

6505011315619

NSN

6505-01-131-5619

MFG

SCHEIN PHARMACEUTICAL INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS METHYLPREDNISOLONE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE TABLETS USP 4MG I.S. 21S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 21 TABLETS PER PACKAGE; PACKAGE SHALL FACILITATE DIRECTION FOR A 6 DAY DRUG THERAPY REGIMEN OF 6 TABLETS ON DAY 1,5 ON DAY 2,4 ON DAY 3,ETC
THERAPEUTIC EQUIVALENT: MEDROL DOSEPAK BY UPJOHN

NDC00536-4036-44

METHYLPREDNISOLONE TABLETS,USP

NSN, MFG P/N

6505011315619

NSN

6505-01-131-5619

View More Info

NDC00536-4036-44

METHYLPREDNISOLONE TABLETS,USP

NSN, MFG P/N

6505011315619

NSN

6505-01-131-5619

MFG

RUGBY GROUP INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS METHYLPREDNISOLONE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE TABLETS USP 4MG I.S. 21S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 21 TABLETS PER PACKAGE; PACKAGE SHALL FACILITATE DIRECTION FOR A 6 DAY DRUG THERAPY REGIMEN OF 6 TABLETS ON DAY 1,5 ON DAY 2,4 ON DAY 3,ETC
THERAPEUTIC EQUIVALENT: MEDROL DOSEPAK BY UPJOHN

42-05

MULTIVITAMIN SOLUTION FOR INJECTION

NSN, MFG P/N

6505011315620

NSN

6505-01-131-5620

View More Info

42-05

MULTIVITAMIN SOLUTION FOR INJECTION

NSN, MFG P/N

6505011315620

NSN

6505-01-131-5620

MFG

LYPHOMED INC DIV OF FUJISAWA USA INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 25.000 MILLIGRAMS DEXPANTHENOL ACTIVE INGREDIENT AND 100.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 15.000 MILLIGRAMS PYRIDOXINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS RIBOFLAVIN
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: CONCENTRATE TO BE DILUTED IN NOT LESS THAN 500 ML INFUSION FLUID
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: ACTIVE INGREDIENT AND 50.000 MILLIGRAMS THIAMINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10000.000 INTERNATIONAL UNITS VITAMIN A ACTIVE INGREDIENT AND 1000.000 INTERNATIONAL UNITS VITAMIN D ACTIVE INGREDIENT AND 5.000 INTERNATIONAL UNITS VITAMIN E ACTIVE
~2: INGREDIENT

NDC00381-0243-05

MULTIVITAMIN SOLUTION FOR INJECTION

NSN, MFG P/N

6505011315620

NSN

6505-01-131-5620

View More Info

NDC00381-0243-05

MULTIVITAMIN SOLUTION FOR INJECTION

NSN, MFG P/N

6505011315620

NSN

6505-01-131-5620

MFG

CARTER-GLOGAU LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 25.000 MILLIGRAMS DEXPANTHENOL ACTIVE INGREDIENT AND 100.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 15.000 MILLIGRAMS PYRIDOXINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS RIBOFLAVIN
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: CONCENTRATE TO BE DILUTED IN NOT LESS THAN 500 ML INFUSION FLUID
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: ACTIVE INGREDIENT AND 50.000 MILLIGRAMS THIAMINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10000.000 INTERNATIONAL UNITS VITAMIN A ACTIVE INGREDIENT AND 1000.000 INTERNATIONAL UNITS VITAMIN D ACTIVE INGREDIENT AND 5.000 INTERNATIONAL UNITS VITAMIN E ACTIVE
~2: INGREDIENT

NDC00469-0690-23

MULTIVITAMIN SOLUTION FOR INJECTION

NSN, MFG P/N

6505011315620

NSN

6505-01-131-5620

View More Info

NDC00469-0690-23

MULTIVITAMIN SOLUTION FOR INJECTION

NSN, MFG P/N

6505011315620

NSN

6505-01-131-5620

MFG

LYPHOMED INC DIV OF FUJISAWA USA INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 25.000 MILLIGRAMS DEXPANTHENOL ACTIVE INGREDIENT AND 100.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 15.000 MILLIGRAMS PYRIDOXINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS RIBOFLAVIN
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: CONCENTRATE TO BE DILUTED IN NOT LESS THAN 500 ML INFUSION FLUID
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: ACTIVE INGREDIENT AND 50.000 MILLIGRAMS THIAMINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10000.000 INTERNATIONAL UNITS VITAMIN A ACTIVE INGREDIENT AND 1000.000 INTERNATIONAL UNITS VITAMIN D ACTIVE INGREDIENT AND 5.000 INTERNATIONAL UNITS VITAMIN E ACTIVE
~2: INGREDIENT

AVITENE

COLLAGEN,MICROFIBRI

NSN, MFG P/N

6505011316019

NSN

6505-01-131-6019

View More Info

AVITENE

COLLAGEN,MICROFIBRI

NSN, MFG P/N

6505011316019

NSN

6505-01-131-6019

MFG

DU PONT CRITICAL CARE INC SUB OF E I DU PONT DE NEMOURS AND CO INC

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 1 GM JAR; BOVINE ORIGIN; FOR USE AS AN ADJUNCT TO HEMOSTASIS

NDC20993-0001-01

COLLAGEN,MICROFIBRI

NSN, MFG P/N

6505011316019

NSN

6505-01-131-6019

View More Info

NDC20993-0001-01

COLLAGEN,MICROFIBRI

NSN, MFG P/N

6505011316019

NSN

6505-01-131-6019

MFG

DU PONT CRITICAL CARE INC SUB OF E I DU PONT DE NEMOURS AND CO INC

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 1 GM JAR; BOVINE ORIGIN; FOR USE AS AN ADJUNCT TO HEMOSTASIS

NDC00378-3000-05

MECLOFENAMATE SODIUM CAPSULES,USP

NSN, MFG P/N

6505011316930

NSN

6505-01-131-6930

View More Info

NDC00378-3000-05

MECLOFENAMATE SODIUM CAPSULES,USP

NSN, MFG P/N

6505011316930

NSN

6505-01-131-6930

MFG

MYLAN PHARMACEUTICALS INC

Description

(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.38 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 8.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.032 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.63 POUNDS
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MECLOFENAMATE SODIUM CAPSULES USP 100MG 500S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 100MG MECLOFENAMATE SOLIUM ACTIVE INGREDIENT

NDC00536-4003-05

MECLOFENAMATE SODIUM CAPSULES,USP

NSN, MFG P/N

6505011316930

NSN

6505-01-131-6930

View More Info

NDC00536-4003-05

MECLOFENAMATE SODIUM CAPSULES,USP

NSN, MFG P/N

6505011316930

NSN

6505-01-131-6930

MFG

RUGBY GROUP INC

Description

(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.38 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 8.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.032 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.63 POUNDS
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MECLOFENAMATE SODIUM CAPSULES USP 100MG 500S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 100MG MECLOFENAMATE SOLIUM ACTIVE INGREDIENT

NDC00591-5637-03

MECLOFENAMATE SODIUM CAPSULES,USP

NSN, MFG P/N

6505011316930

NSN

6505-01-131-6930

View More Info

NDC00591-5637-03

MECLOFENAMATE SODIUM CAPSULES,USP

NSN, MFG P/N

6505011316930

NSN

6505-01-131-6930

MFG

DANBURY PHARMACAL INC

Description

(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.38 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 8.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.032 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.63 POUNDS
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MECLOFENAMATE SODIUM CAPSULES USP 100MG 500S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 100MG MECLOFENAMATE SOLIUM ACTIVE INGREDIENT

110F

SODIUM PHOSPHATES ORAL SOLUTION,USP

NSN, MFG P/N

6505011317810

NSN

6505-01-131-7810

View More Info

110F

SODIUM PHOSPHATES ORAL SOLUTION,USP

NSN, MFG P/N

6505011317810

NSN

6505-01-131-7810

MFG

FLEET COMPANY INCORPORATED C. B. DBA FLEET

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 480.000 MILLIGRAMS SODIUM BIPHOSPHATE PER MILLILITER AND 180.000 MILLIGRAMS SODIUM PHOSPHATE PER MILLILITER
FLAVOR: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 24

NDC00132-0109-08

SODIUM PHOSPHATES ORAL SOLUTION,USP

NSN, MFG P/N

6505011317810

NSN

6505-01-131-7810

View More Info

NDC00132-0109-08

SODIUM PHOSPHATES ORAL SOLUTION,USP

NSN, MFG P/N

6505011317810

NSN

6505-01-131-7810

MFG

FLEET COMPANY INCORPORATED C. B. DBA FLEET

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 480.000 MILLIGRAMS SODIUM BIPHOSPHATE PER MILLILITER AND 180.000 MILLIGRAMS SODIUM PHOSPHATE PER MILLILITER
FLAVOR: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 24

PHOSPHO-SODA

SODIUM PHOSPHATES ORAL SOLUTION,USP

NSN, MFG P/N

6505011317810

NSN

6505-01-131-7810

View More Info

PHOSPHO-SODA

SODIUM PHOSPHATES ORAL SOLUTION,USP

NSN, MFG P/N

6505011317810

NSN

6505-01-131-7810

MFG

FLEET COMPANY INCORPORATED C. B. DBA FLEET

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 480.000 MILLIGRAMS SODIUM BIPHOSPHATE PER MILLILITER AND 180.000 MILLIGRAMS SODIUM PHOSPHATE PER MILLILITER
FLAVOR: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 24

FLUOR-I-STRIP-A.T.

FLUORESCEIN SODIUM OPHTHALMIC STRIPS,USP

NSN, MFG P/N

6505011319687

NSN

6505-01-131-9687

View More Info

FLUOR-I-STRIP-A.T.

FLUORESCEIN SODIUM OPHTHALMIC STRIPS,USP

NSN, MFG P/N

6505011319687

NSN

6505-01-131-9687

MFG

WYETH

Description

IMMEDIATE CONTAINER QUANTITY: 100
IMMEDIATE CONTAINER TYPE: ENVELOPE
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 2 APPLICATOR STRIPS
SPECIAL FEATURES: 1.0 MG. FLUORESCEIN SODIUM PER STRIP
UNIT PACKAGE TYPE: BOX